Role of oxidative stress in cardiac hypertrophy and remodeling.

Cardiac adaptation in response to intrinsic or external stress involves a complex process of chamber remodeling and myocyte molecular modifications. A fundamental response to increased biomechanical stress is cardiomyocyte and chamber hypertrophy. Although this may provide initial salutary compensation to the stress, sustained hypertrophic stimulation becomes maladaptive, worsening morbidity and mortality risks because of congestive heart failure and sudden death.1 Growing evidence highlights oxidative and nitrosative stresses as important mechanisms for this maladaptation.2–9 Oxidative stress occurs when excess reactive oxygen species (ROS) are generated that cannot be adequately countered by intrinsic antioxidant systems. Superoxide anion (O2−) can further combine with NO, forming reactive compounds such as peroxynitrite, generating nitroso-redox imbalance.4 ROS generation is a normal component of oxidative phosphorylation and plays a role in normal redox control of physiological signaling pathways.5,8,9 However, excessive ROS generation triggers cell dysfunction, lipid peroxidation, and DNA mutagenesis and can lead to irreversible cell damage or death.5,8,9 In this review, we discuss recent experimental evidence for the role of oxidant stress on cardiac remodeling, focusing on pressure- overload–induced hypertrophy and dilation. ROS include free radicals such as superoxide (O2−) and hydroxyl radical and compounds such as hydrogen peroxide (H2O2) that can be converted to radicals, and they participate in both normal and pathologic biochemical reactions.9 O2− is formed intracellularly (Figure 1) by activation of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase or xanthine oxidase (XO), uncoupling of NO synthase (NOS), and electron transport and “leakage” during oxidative phosphorylation in the mitochondria.5,8,9 H2O2 can generate the highly reactive hydroxyl radical via Fenton chemistry under pathological conditions.9 Figure 1. General schematic of generation pathways for ROS and antioxidant systems in the heart. Low levels of ROS are thought to …

[1]  D. Kass,et al.  Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. , 2006, Free radical biology & medicine.

[2]  H. Tsutsui,et al.  Mitochondrial oxidative stress, DNA damage, and heart failure. , 2006, Antioxidants & redox signaling.

[3]  Min Zhang,et al.  NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. , 2006, Cardiovascular research.

[4]  A. Zima,et al.  Redox regulation of cardiac calcium channels and transporters. , 2006, Cardiovascular research.

[5]  D. Kwiatkowski,et al.  Requirement of Rac1 in the development of cardiac hypertrophy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Sunagawa,et al.  Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice , 2006, Circulation.

[7]  A. Shah,et al.  Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. , 2006, Journal of the American College of Cardiology.

[8]  R. Saraiva,et al.  Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy , 2006, Circulation research.

[9]  Marc A Pfeffer,et al.  Controversies in ventricular remodelling , 2006, The Lancet.

[10]  T. Münzel,et al.  Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[11]  R. Saraiva,et al.  Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium , 2005, Circulation.

[12]  K. Rockett,et al.  Stoichiometric Relationships Between Endothelial Tetrahydrobiopterin, Endothelial NO Synthase (eNOS) Activity, and eNOS Coupling in Vivo: Insights From Transgenic Mice With Endothelial-Targeted GTP Cyclohydrolase 1 and eNOS Overexpression , 2005, Circulation research.

[13]  W. Leary,et al.  Allopurinol or Oxypurinol in Heart Failure Therapy – a Promising New Development or End of Story? , 2005, Cardiovascular Drugs and Therapy.

[14]  J. Duncan,et al.  Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy. , 2005, American journal of physiology. Heart and circulatory physiology.

[15]  R. Wessely,et al.  Aortic Coarctation Visualized by 16-Row Detector Multislice Computed Tomography , 2005 .

[16]  J. Loscalzo,et al.  ATVB In Focus Redox Mechanisms in Blood Vessels , 2005 .

[17]  K. Nakao,et al.  Calcineurin–Nuclear Factor of Activated T Cells Pathway–Dependent Cardiac Remodeling in Mice Deficient in Guanylyl Cyclase A, a Receptor for Atrial and Brain Natriuretic Peptides , 2005, Circulation.

[18]  C. Szabó,et al.  Nitrosative stress and pharmacological modulation of heart failure. , 2005, Trends in pharmacological sciences.

[19]  D. Kass,et al.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. , 2005, The Journal of clinical investigation.

[20]  S. Yusuf,et al.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.

[21]  R. Liao,et al.  &agr;-Adrenergic Receptor–Stimulated Hypertrophy in Adult Rat Ventricular Myocytes Is Mediated via Thioredoxin-1–Sensitive Oxidative Modification of Thiols on Ras , 2005, Circulation.

[22]  J. Stamler,et al.  NO/redox disequilibrium in the failing heart and cardiovascular system. , 2005, The Journal of clinical investigation.

[23]  Frank J Giordano,et al.  Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.

[24]  J. Keaney,et al.  Cytokine-Stimulated GTP Cyclohydrolase I Expression in Endothelial Cells Requires Coordinated Activation of Nuclear Factor-&kgr;B and Stat1/Stat3 , 2005, Circulation research.

[25]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.

[26]  Simon J. Walker,et al.  A Nox2-containing NADPH oxidase contributes to cardiac remodeling after myocardial infarction , 2005 .

[27]  E. Marbán,et al.  Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy , 2004, Circulation research.

[28]  J. Hare Nitroso-redox balance in the cardiovascular system. , 2004, The New England journal of medicine.

[29]  J. Hare,et al.  Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Shah,et al.  Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[31]  D. Pimentel,et al.  S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide , 2004, Nature Medicine.

[32]  H. Drexler,et al.  Allopurinol Attenuates Left Ventricular Remodeling and Dysfunction After Experimental Myocardial Infarction: A New Action for an Old Drug? , 2004, Circulation.

[33]  J. Fukuto,et al.  Inhibition of the yeast metal reductase heme protein fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO. , 2004, Free radical biology & medicine.

[34]  R. Ferrari,et al.  Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[35]  N. Blau,et al.  The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. , 2004, Molecular genetics and metabolism.

[36]  Masahiro Ito,et al.  Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.

[37]  J. Lambeth NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.

[38]  N. Alp,et al.  Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[39]  A. Takeshita,et al.  Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice , 2004, Circulation.

[40]  W. Colucci,et al.  Regulation of Matrix Metalloproteinases by Cytokines and Reactive Oxygen/Nitrogen Species in the Myocardium , 2004, Heart Failure Reviews.

[41]  M. Hori,et al.  Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Sabri,et al.  Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. , 2003, Antioxidants & redox signaling.

[43]  Don P Giddens,et al.  Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. , 2003, American journal of physiology. Heart and circulatory physiology.

[44]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[45]  H. Yamawaki,et al.  Thioredoxin: A Key Regulator of Cardiovascular Homeostasis , 2003, Circulation research.

[46]  T. Cheng,et al.  Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. , 2003, Journal of the American College of Cardiology.

[47]  F. Hofmann,et al.  Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. , 2003, Circulation research.

[48]  Jing Liu,et al.  Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. , 2003, The Journal of clinical investigation.

[49]  A. Shah,et al.  Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.

[50]  U. Laufs,et al.  Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment , 2003, Circulation.

[51]  D. Harrison,et al.  Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols , 2003, Journal of Biological Chemistry.

[52]  A. Shah,et al.  Increased myocardial NADPH oxidase activity in human heart failure. , 2003, Journal of the American College of Cardiology.

[53]  D. Sawyer,et al.  H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. , 2003, Journal of molecular and cellular cardiology.

[54]  Michael D. Schneider,et al.  Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. , 2003, The Journal of clinical investigation.

[55]  Steven M Holland,et al.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. , 2003, The Journal of clinical investigation.

[56]  A. Shah,et al.  Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II , 2003, The Journal of Biological Chemistry.

[57]  C. Chiueh,et al.  Cyclic GMP-dependent Protein Kinase Regulates the Expression of Thioredoxin and Thioredoxin Peroxidase-1 during Hormesis in Response to Oxidative Stress-induced Apoptosis* , 2003, The Journal of Biological Chemistry.

[58]  J. Salerno,et al.  Nitric oxide synthases: domain structure and alignment in enzyme function and control. , 2003, Frontiers in bioscience : a journal and virtual library.

[59]  F. Spinale Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. , 2002, Circulation research.

[60]  F. Murad,et al.  Protein Nitration in Cardiovascular Diseases , 2002, Pharmacological Reviews.

[61]  G. Fiskum,et al.  The Role of Tetrahydrobiopterin in the Regulation of Neuronal Nitric-oxide Synthase-generated Superoxide* , 2002, The Journal of Biological Chemistry.

[62]  A. Shah,et al.  Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure , 2002, Hypertension.

[63]  H. Drexler,et al.  Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Cristol,et al.  Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative Stress , 2002, Hypertension.

[65]  Tomoya Yamashita,et al.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. , 2002, The Journal of clinical investigation.

[66]  D. Sorescu,et al.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. , 2002, Congestive heart failure.

[67]  K. Channon,et al.  Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.

[68]  D. Sawyer,et al.  Role of oxidative stress in myocardial hypertrophy and failure. , 2002, Journal of molecular and cellular cardiology.

[69]  D. Sawyer,et al.  Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. , 2002, American journal of physiology. Cell physiology.

[70]  R. Cohen,et al.  Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. , 2002, The Journal of clinical investigation.

[71]  M. Hori,et al.  The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. , 2002, Journal of the American College of Cardiology.

[72]  B. Bozkurt,et al.  Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. , 2002, Cardiovascular research.

[73]  Qin M. Chen,et al.  Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. , 2002, The Journal of pharmacology and experimental therapeutics.

[74]  D. Kass,et al.  Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart , 2002, Circulation research.

[75]  A. Shah,et al.  Essential Role of the NADPH Oxidase Subunit p47phox in Endothelial Cell Superoxide Production in Response to Phorbol Ester and Tumor Necrosis Factor-&agr; , 2002, Circulation research.

[76]  Yasushi Matsumura,et al.  Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.

[77]  A. Shah,et al.  Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice , 2002, Circulation.

[78]  C. Trautwein,et al.  Gene Transfer of cGMP-Dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes , 2002, Hypertension.

[79]  D. Sawyer,et al.  Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. , 2002, American journal of physiology. Cell physiology.

[80]  Y. Zou,et al.  Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. , 2001, Biochemical and biophysical research communications.

[81]  A. Takeshita,et al.  8-Oxo-dGTPase, Which Prevents Oxidative Stress-Induced DNA Damage, Increases in the Mitochondria From Failing Hearts , 2001, Circulation.

[82]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[83]  J. Ross,et al.  Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. , 2001, The Journal of clinical investigation.

[84]  K. Node,et al.  Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. , 2001, The Journal of clinical investigation.

[85]  D. Kass,et al.  Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy , 2001, Circulation.

[86]  L. Dell’Italia,et al.  Differential MAP kinase activation and Na(+)/H(+) exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes. , 2001, American journal of physiology. Cell physiology.

[87]  P. Anversa,et al.  Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy , 2001, Circulation research.

[88]  J. Knowles,et al.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. , 2001, The Journal of clinical investigation.

[89]  D. Sawyer,et al.  MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. , 2001, Journal of molecular and cellular cardiology.

[90]  D. Kang,et al.  Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction , 2001, Circulation research.

[91]  D. Garbers,et al.  A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[92]  W. Little,et al.  Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart Failure , 2001, Circulation.

[93]  Koichi Tanaka,et al.  Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. , 2001, Journal of the American College of Cardiology.

[94]  D. Sawyer,et al.  Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. , 2001, Journal of molecular and cellular cardiology.

[95]  P. Tsao,et al.  Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase , 2001, Journal of cellular biochemistry. Supplement.

[96]  W. Colucci,et al.  Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. , 2001, American journal of physiology. Cell physiology.

[97]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[98]  P. Bernocchi,et al.  Enhanced expression and activity of xanthine oxidoreductase in the failing heart. , 2001, Journal of molecular and cellular cardiology.

[99]  D. Kass,et al.  cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. , 2000, American journal of physiology. Heart and circulatory physiology.

[100]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[101]  O. Hess,et al.  Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. , 2000, Journal of cardiovascular pharmacology.

[102]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[103]  T. Horio,et al.  Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. , 2000, Hypertension.

[104]  D. Kass,et al.  Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. , 1999, Circulation research.

[105]  R. Busse,et al.  Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. , 1999, Circulation.

[106]  S. Ball,et al.  Modulation of recombinant human cardiac L‐type Ca2+ channel α1C subunits by redox agents and hypoxia , 1999, The Journal of physiology.

[107]  J. Zweier,et al.  Superoxide Generation from Endothelial Nitric-oxide Synthase , 1998, The Journal of Biological Chemistry.

[108]  K. Mihara,et al.  Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. , 1998, Circulation.

[109]  A. Samarel,et al.  Hydrogen peroxide activates mitogen-activated protein kinases and Na+-H+ exchange in neonatal rat cardiac myocytes. , 1998, Circulation research.

[110]  A. Omran,et al.  Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[111]  D. Chatel,et al.  Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. , 1998, Circulation.

[112]  E. Okabe,et al.  Superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum through ryanodine receptor Ca2+ channel. , 1998, Molecular pharmacology.

[113]  T. Lüscher,et al.  Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. , 1997, Circulation.

[114]  L. Becker,et al.  Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. , 1997, Circulation research.

[115]  P. Hassoun,et al.  Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. , 1996, The American journal of physiology.

[116]  P. Singal,et al.  Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.

[117]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[118]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[119]  ThomasHeitzer,et al.  Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia , 1996 .

[120]  M. Olschewski,et al.  Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. , 1996, Circulation.

[121]  P. Hassoun,et al.  Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. , 1995, The American journal of physiology.

[122]  M. Hori,et al.  Ebselen protects against ischemia-reperfusion injury in a canine model of myocardial infarction. , 1994, The American journal of physiology.

[123]  J. McMurray,et al.  Evidence of oxidative stress in chronic heart failure in humans. , 1993, European heart journal.

[124]  S. Abramson,et al.  Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. , 1992, The Journal of clinical investigation.